Call for prior art: Can you find better art for this patent that claims novelty based on a comparison of device output with a known constant?
U.S. Patent No. 7,888,125 (Theranos) Filed March 24, 2006 Priority May 9, 2005.
Claim 1 recites:
A method of improving the accuracy of calibrating a fluidic system, comprising:
a) providing a system for detecting an analyte in a bodily fluid from a subject comprising a fluidic device for providing said bodily fluid, said fluidic device having a calibration assembly and a reader assembly for detecting the presence of said analyte;
b) measuring one or more parameters that are fitted to a calibration curve associated with said fluidic device;
c) comparing said one or more parameters with predetermined parameters associated with said fluidic device;
d) adjusting a signal output from the fluidic device by multiplying a ratio of said predetermined parameters to said one or more parameters, wherein the ratio is selected from the group consisting of: a ratio of maximum signal level during factory calibration to maximum signal level measured within the assay, and a ratio of minimun signal level during factory calibration to minimum signal level measured within an assay.
For this university battle I'll pit Duke and one of their then Ph.D. student's thesis (which results in a company Advanced Liquid Logics bought by Illumina) against Stanford and one of their drop outs (who has a company Theranos).
Can you find better prior art than Duke's:
Amicrofluidic lab-on-a-chip (LoC) platform for in vitro measurement of glucose for clinical diagnostic applications is presented in this paper. The LoC uses a discrete droplet format in contrast to conventional continuous flow microfluidic systems. The droplets act as solution-phase reaction chambers and are manipulated using the electrowetting effect. Glucose is measured using a colorimetric enzyme-kinetic method based on Trinder’s reaction. The color change is detected using an absorbance measurement system consisting of a light emitting diode and a photodiode. The linear range of the assay is 9–100 mg/dl using a sample dilution factor of 2 and 15–300 mg/dl using a sample dilution factor of 3.
The voltage V(t) is directly proportional to the light intensity incident on the photodiode and is related to the absorbance by the following equation: A(t) = ln {(V0 – Vdark) / (V(t) – Vdark)} (5) V0 corresponds to zero absorbance (or 100% transmittance), and Vdark corresponds to the voltage output of the photodiode under dark conditions. The rate of the change of absorbance dA(t)/dt is equivalent to the reaction rate, and is related to the glucose concentration by Eq. (3).
-Srinivasan, et al., Droplet-based microfluidic lab-on-a-chip for glucose detection, Analytica Clinica Acta 507 (2004), 145-50. (equation edited to conform).